Please try another search
Surgical Science Sweden AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 227.29 million compared to SEK 250.11 million a year ago. Net income was SEK 97.96 million compared to SEK 116.52 million a year ago. Basic earnings per share from continuing operations was SEK 1.92 compared to SEK 2.29 a year ago. Diluted earnings per share from continuing operations was SEK 1.92 compared to SEK 2.29 a year ago.For the full year, sales was SEK 882.85 million compared to SEK 802.54 million a year ago. Net income was SEK 233.97 million compared to SEK 187.97 million a year ago. Basic earnings per share from continuing operations was SEK 4.59 compared to SEK 3.7 a year ago. Diluted earnings per share from continuing operations was SEK 4.59 compared to SEK 3.69 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 227.29 | 210.25 | 216.24 | 229.08 |
Gross Profit | 162.43 | 145.02 | 146.74 | 158.68 |
Operating Income | 53.93 | 46.52 | 41.82 | 49.01 |
Net Income | 97.96 | 47.4 | 38.79 | 49.82 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 4702.67 | 4920.2 | 4925.39 | 4668.51 |
Total Liabilities | 357.46 | 400.75 | 448.04 | 416.45 |
Total Equity | 4345.21 | 4519.46 | 4477.36 | 4252.06 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 39.6 | 53.12 | 85.1 | 60.48 |
Cash From Investing Activities | -11.75 | -16.08 | -9.39 | -6.91 |
Cash From Financing Activities | 8.97 | -5.08 | 14.76 | -2.8 |
Net Change in Cash | 28.31 | 31.64 | 92.34 | 48.35 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review